Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain.
Santiago MorenoAntonio RiveroPere VentayolVicenç FalcóMiguel Torralba González de SusoMelanie SchroederVictoria NechesLaura Amanda Vallejo-AparicioIsaac MackenzieMatthew TurnerCale HarrisonPublished in: Infectious diseases and therapy (2023)
ATLAS, NCT02951052; ATLAS-2M, NCT03299049; FLAIR, NCT02938520.